Clonal Hematopoiesis and Cardiovascular Disease Risk After Cancer Therapy in Patients With Solid Tumors
In this cohort study, CHIP was associated with increased CVD risk in patients with solid tumors receiving cancer therapy. This finding suggests incorporating CHIP status may improve cardio-oncology treatment of cancer survivors.
Authors
- Robert W. Corty (ORCID: https://orcid.org/0000-0002-6787-9051)
- Eric T. Shinohara (ORCID: https://orcid.org/0000-0001-9322-2531)
- Derek Shyr (ORCID: https://orcid.org/0000-0002-2345-3390)
- Leo Luo
- Kun Zhao (ORCID: https://orcid.org/0000-0001-9871-4957)
- Ashwin Kishtagari
- Ben Ho Park
- Yash Pershad
- J. Brett Heimlich
- Alexander G. Bick
Institutions
- University of Alabama at Birmingham (US)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- JAMA Oncology
- Published
- 2026-01-08
- DOI
- https://doi.org/10.1001/jamaoncol.2025.5785
- Primary Topic
- Chemotherapy-induced cardiotoxicity and mitigation
- Type
- article
- Field-Weighted Citation Impact
- 0.00